Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy

Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy

Immune checkpoint blockade (ICB) therapies have significantly improved the prognosis and shown considerable promise for cancer therapy; however, differences in ICB treatment efficacy between the elderly and young are unknown. We analyzed the studies enrolled in the meta-analysis using the deft appro...

Full description

Bibliographic Details
Main Authors: Qi-jie Zhang, Jiao-chen Luan, Le-bin Song, Rong Cong, Cheng-jian Ji, Xiang Zhou, Jia-dong Xia, Ning-hong Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint blockade
age
immune profiles
therapy efficacy
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.657575/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.657575/full

Similar Items